ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 99 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $152,272 | -99.9% | 7,606 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $196,463,000 | +54.7% | 7,606 | +43.2% | 0.00% | +50.0% |
| Q1 2018 | $126,981,000 | +70445.0% | 5,313 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $180,000 | -18.6% | 5,313 | -49.1% | 0.00% | +100.0% |
| Q3 2017 | $221,000 | +21.4% | 10,428 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $182,000 | 0.0% | 10,428 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $182,000 | +3.4% | 10,428 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $176,000 | +2.9% | 10,428 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $171,000 | +8.2% | 10,428 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $158,000 | +18.8% | 10,428 | +31.6% | 0.00% | 0.0% |
| Q3 2015 | $133,000 | -36.1% | 7,926 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $208,000 | – | 7,926 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| C Partners Holding GmbH | 1,662,128 | $29,037,000 | 9.28% |
| GREAT POINT PARTNERS LLC | 608,650 | $10,645,000 | 4.68% |
| Opaleye Management Inc. | 255,000 | $4,460,000 | 2.07% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 326,530 | $5,721,000 | 0.47% |
| Granite Point Capital Management, L.P. | 61,813 | $1,076,000 | 0.39% |
| WALL STREET ASSOCIATES | 225,000 | $3,935,000 | 0.37% |
| EMERALD ADVISERS, LLC | 322,631 | $5,652,000 | 0.28% |
| Spark Investment Management LLC | 75,500 | $1,317,000 | 0.18% |
| TFS CAPITAL LLC | 98,443 | $1,722,000 | 0.17% |
| PRIVATE ASSET MANAGEMENT INC | 47,690 | $834,000 | 0.14% |